Literature DB >> 35361968

Defining the risk of SARS-CoV-2 variants on immune protection.

Marciela M DeGrace1,2, Elodie Ghedin1,3, Matthew B Frieman4, Florian Krammer5,6, Alba Grifoni7, Arghavan Alisoltani8, Galit Alter9, Rama R Amara10, Ralph S Baric11,12, Dan H Barouch13, Jesse D Bloom14, Louis-Marie Bloyet15, Gaston Bonenfant16, Adrianus C M Boon17, Eli A Boritz1,2,18, Debbie L Bratt1,2,19, Traci L Bricker17, Liliana Brown1,2, William J Buchser20, Juan Manuel Carreño21, Liel Cohen-Lavi22, Tamarand L Darling17, Meredith E Davis-Gardner23, Bethany L Dearlove24, Han Di16, Meike Dittmann25, Nicole A Doria-Rose1,18, Daniel C Douek1,18, Christian Drosten26, Venkata-Viswanadh Edara23, Ali Ellebedy27, Thomas P Fabrizio28, Guido Ferrari29, Will M Fischer30, William C Florence1,2, Ron A M Fouchier31, John Franks28, Adolfo García-Sastre21,32,33,34,35, Adam Godzik8, Ana Silvia Gonzalez-Reiche36, Aubree Gordon37, Bart L Haagmans31, Peter J Halfmann38, David D Ho39, Michael R Holbrook40, Yaoxing Huang39, Sarah L James41, Lukasz Jaroszewski8, Trushar Jeevan28, Robert M Johnson4, Terry C Jones26,41, Astha Joshi17, Yoshihiro Kawaoka38,42,43, Lisa Kercher28, Marion P G Koopmans31, Bette Korber30, Eilay Koren22,44, Richard A Koup1,18, Eric B LeGresley41, Jacob E Lemieux45, Mariel J Liebeskind20, Zhuoming Liu15, Brandi Livingston28, James P Logue4, Yang Luo39, Adrian B McDermott1,18, Margaret J McElrath46, Victoria A Meliopoulos28, Vineet D Menachery47, David C Montefiori48, Barbara Mühlemann26,41, Vincent J Munster49, Jenny E Munt11, Manoj S Nair39, Antonia Netzl41, Anna M Niewiadomska50, Sijy O'Dell1,18, Andrew Pekosz51, Stanley Perlman52, Marjorie C Pontelli15, Barry Rockx31, Morgane Rolland24, Paul W Rothlauf15, Sinai Sacharen22,44, Richard H Scheuermann50, Stephen D Schmidt1,18, Michael Schotsaert21,35, Stacey Schultz-Cherry28, Robert A Seder1,18, Mayya Sedova8, Alessandro Sette7,53, Reed S Shabman1,2, Xiaoying Shen29, Pei-Yong Shi54, Maulik Shukla55,56, Viviana Simon21,32,33,35, Spencer Stumpf15, Nancy J Sullivan1,18, Larissa B Thackray17, James Theiler30, Paul G Thomas57, Sanja Trifkovic28, Sina Türeli41, Samuel A Turner41, Maria A Vakaki20, Harm van Bakel36, Laura A VanBlargan17, Leah R Vincent1,2, Zachary S Wallace50,58, Li Wang16, Maple Wang39, Pengfei Wang39, Wei Wang59, Scott C Weaver47, Richard J Webby28, Carol D Weiss59, David E Wentworth16, Stuart M Weston4, Sean P J Whelan15, Bradley M Whitener17, Samuel H Wilks41, Xuping Xie54, Baoling Ying17, Hyejin Yoon30, Bin Zhou16, Tomer Hertz60, Derek J Smith61, Michael S Diamond62,63,64,65, Diane J Post66,67, Mehul S Suthar68.   

Abstract

The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants jeopardizes the protective antiviral immunity induced after infection or vaccination. To address the public health threat caused by the increasing SARS-CoV-2 genomic diversity, the National Institute of Allergy and Infectious Diseases within the National Institutes of Health established the SARS-CoV-2 Assessment of Viral Evolution (SAVE) programme. This effort was designed to provide a real-time risk assessment of SARS-CoV-2 variants that could potentially affect the transmission, virulence, and resistance to infection- and vaccine-induced immunity. The SAVE programme is a critical data-generating component of the US Government SARS-CoV-2 Interagency Group to assess implications of SARS-CoV-2 variants on diagnostics, vaccines and therapeutics, and for communicating public health risk. Here we describe the coordinated approach used to identify and curate data about emerging variants, their impact on immunity and effects on vaccine protection using animal models. We report the development of reagents, methodologies, models and notable findings facilitated by this collaborative approach and identify future challenges. This programme is a template for the response to rapidly evolving pathogens with pandemic potential by monitoring viral evolution in the human population to identify variants that could reduce the effectiveness of countermeasures.
© 2022. Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35361968      PMCID: PMC9345323          DOI: 10.1038/s41586-022-04690-5

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   69.504


  109 in total

1.  Acute spontaneous streptococcal myositis. Case report.

Authors:  J E Jansen; J A Retpen
Journal:  Acta Chir Scand       Date:  1988-04

Review 2.  SARS-CoV-2 vaccines in development.

Authors:  Florian Krammer
Journal:  Nature       Date:  2020-09-23       Impact factor: 49.962

Review 3.  HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens.

Authors:  Will Fischer; Elena E Giorgi; Srirupa Chakraborty; Kien Nguyen; Tanmoy Bhattacharya; James Theiler; Pablo A Goloboff; Hyejin Yoon; Werner Abfalterer; Brian T Foley; Houriiyah Tegally; James Emmanuel San; Tulio de Oliveira; Sandrasegaram Gnanakaran; Bette Korber
Journal:  Cell Host Microbe       Date:  2021-06-03       Impact factor: 31.316

4.  SARS-CoV-2 Variants of Concern in the United States-Challenges and Opportunities.

Authors:  Rochelle P Walensky; Henry T Walke; Anthony S Fauci
Journal:  JAMA       Date:  2021-03-16       Impact factor: 157.335

Review 5.  The variant gambit: COVID-19's next move.

Authors:  Jessica A Plante; Brooke M Mitchell; Kenneth S Plante; Kari Debbink; Scott C Weaver; Vineet D Menachery
Journal:  Cell Host Microbe       Date:  2021-03-01       Impact factor: 31.316

6.  Evidence for retained spike-binding and neutralizing activity against emerging SARS-CoV-2 variants in serum of COVID-19 mRNA vaccine recipients.

Authors:  Juan Manuel Carreño; Hala Alshammary; Gagandeep Singh; Ariel Raskin; Fatima Amanat; Angela Amoako; Ana Silvia Gonzalez-Reiche; Adriana van de Guchte; Paris Study Group; Komal Srivastava; Emilia Mia Sordillo; D Noah Sather; Harm van Bakel; Florian Krammer; Viviana Simon
Journal:  EBioMedicine       Date:  2021-10-20       Impact factor: 11.205

7.  Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.

Authors:  Amarendra Pegu; Sarah E O'Connell; Stephen D Schmidt; Sijy O'Dell; Chloe A Talana; Lilin Lai; Jim Albert; Evan Anderson; Hamilton Bennett; Kizzmekia S Corbett; Britta Flach; Lisa Jackson; Brett Leav; Julie E Ledgerwood; Catherine J Luke; Mat Makowski; Martha C Nason; Paul C Roberts; Mario Roederer; Paulina A Rebolledo; Christina A Rostad; Nadine G Rouphael; Wei Shi; Lingshu Wang; Alicia T Widge; Eun Sung Yang; John H Beigel; Barney S Graham; John R Mascola; Mehul S Suthar; Adrian B McDermott; Nicole A Doria-Rose; Jae Arega; John H Beigel; Wendy Buchanan; Mohammed Elsafy; Binh Hoang; Rebecca Lampley; Aparna Kolhekar; Hyung Koo; Catherine Luke; Mamodikoe Makhene; Seema Nayak; Rhonda Pikaart-Tautges; Paul C Roberts; Janie Russell; Elisa Sindall; Jim Albert; Pratap Kunwar; Mat Makowski; Evan J Anderson; Amer Bechnak; Mary Bower; Andres F Camacho-Gonzalez; Matthew Collins; Ana Drobeniuc; Venkata Viswanadh Edara; Srilatha Edupuganti; Katharine Floyd; Theda Gibson; Cassie M Grimsley Ackerley; Brandi Johnson; Satoshi Kamidani; Carol Kao; Colleen Kelley; Lilin Lai; Hollie Macenczak; Michele Paine McCullough; Etza Peters; Varun K Phadke; Paulina A Rebolledo; Christina A Rostad; Nadine Rouphael; Erin Scherer; Amy Sherman; Kathy Stephens; Mehul S Suthar; Mehgan Teherani; Jessica Traenkner; Juton Winston; Inci Yildirim; Lee Barr; Joyce Benoit; Barbara Carste; Joe Choe; Maya Dunstan; Roxanne Erolin; Jana Ffitch; Colin Fields; Lisa A Jackson; Erika Kiniry; Susan Lasicka; Stella Lee; Matthew Nguyen; Stephanie Pimienta; Janice Suyehira; Michael Witte; Hamilton Bennett; Nedim Emil Altaras; Andrea Carfi; Marjorie Hurley; Brett Leav; Rolando Pajon; Wellington Sun; Tal Zaks; Rhea N Coler; Sasha E Larsen; Kathleen M Neuzil; Lisa C Lindesmith; David R Martinez; Jennifer Munt; Michael Mallory; Caitlin Edwards; Ralph S Baric; Nina M Berkowitz; Eli A Boritz; Kevin Carlton; Kizzmekia S Corbett; Pamela Costner; Adrian Creanga; Nicole A Doria-Rose; Daniel C Douek; Britta Flach; Martin Gaudinski; Ingelise Gordon; Barney S Graham; LaSonji Holman; Julie E Ledgerwood; Kwanyee Leung; Bob C Lin; Mark K Louder; John R Mascola; Adrian B McDermott; Kaitlyn M Morabito; Laura Novik; Sarah O'Connell; Sijy O'Dell; Marcelino Padilla; Amarendra Pegu; Stephen D Schmidt; Wei Shi; Phillip A Swanson; Chloe A Talana; Lingshu Wang; Alicia T Widge; Eun Sung Yang; Yi Zhang; James D Chappell; Mark R Denison; Tia Hughes; Xiaotao Lu; Andrea J Pruijssers; Laura J Stevens; Christine M Posavad; Michael Gale; Vineet Menachery; Pei-Yong Shi
Journal:  Science       Date:  2021-08-13       Impact factor: 63.714

8.  Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2.

Authors:  Sabari Nath Neerukonda; Russell Vassell; Rachel Herrup; Shufeng Liu; Tony Wang; Kazuyo Takeda; Ye Yang; Tsai-Lien Lin; Wei Wang; Carol D Weiss
Journal:  PLoS One       Date:  2021-03-10       Impact factor: 3.240

9.  Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.

Authors:  Bette Korber; Will M Fischer; Sandrasegaram Gnanakaran; Hyejin Yoon; James Theiler; Werner Abfalterer; Nick Hengartner; Elena E Giorgi; Tanmoy Bhattacharya; Brian Foley; Kathryn M Hastie; Matthew D Parker; David G Partridge; Cariad M Evans; Timothy M Freeman; Thushan I de Silva; Charlene McDanal; Lautaro G Perez; Haili Tang; Alex Moon-Walker; Sean P Whelan; Celia C LaBranche; Erica O Saphire; David C Montefiori
Journal:  Cell       Date:  2020-07-03       Impact factor: 66.850

10.  Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals.

Authors:  Alison Tarke; John Sidney; Nils Methot; Esther Dawen Yu; Yun Zhang; Jennifer M Dan; Benjamin Goodwin; Paul Rubiro; Aaron Sutherland; Eric Wang; April Frazier; Sydney I Ramirez; Stephen A Rawlings; Davey M Smith; Ricardo da Silva Antunes; Bjoern Peters; Richard H Scheuermann; Daniela Weiskopf; Shane Crotty; Alba Grifoni; Alessandro Sette
Journal:  Cell Rep Med       Date:  2021-07-02
View more
  13 in total

1.  Animal models in SARS-CoV-2 research.

Authors:  Hin Chu; Jasper Fuk-Woo Chan; Kwok-Yung Yuen
Journal:  Nat Methods       Date:  2022-04       Impact factor: 28.547

Review 2.  Autophagy in health and disease: From molecular mechanisms to therapeutic target.

Authors:  Guang Lu; Yu Wang; Yin Shi; Zhe Zhang; Canhua Huang; Weifeng He; Chuang Wang; Han-Ming Shen
Journal:  MedComm (2020)       Date:  2022-07-10

Review 3.  Systems biology of malaria explored with nonhuman primates.

Authors:  Mary R Galinski
Journal:  Malar J       Date:  2022-06-07       Impact factor: 3.469

4.  PARIS and SPARTA: Finding the Achilles' Heel of SARS-CoV-2.

Authors:  Viviana Simon; Vamsi Kota; Ryan F Bloomquist; Hannah B Hanley; David Forgacs; Savita Pahwa; Suresh Pallikkuth; Loren G Miller; Joanna Schaenman; Michael R Yeaman; David Manthei; Joshua Wolf; Aditya H Gaur; Jeremie H Estepp; Komal Srivastava; Juan Manuel Carreño; Frans Cuevas; Ali H Ellebedy; Aubree Gordon; Riccardo Valdez; Sarah Cobey; Elaine F Reed; Ravindra Kolhe; Paul G Thomas; Stacey Schultz-Cherry; Ted M Ross; Florian Krammer
Journal:  mSphere       Date:  2022-05-19       Impact factor: 5.029

Review 5.  Mucosal immune responses to infection and vaccination in the respiratory tract.

Authors:  Robert C Mettelman; E Kaitlynn Allen; Paul G Thomas
Journal:  Immunity       Date:  2022-05-10       Impact factor: 43.474

6.  A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spike.

Authors:  Bernadeta Dadonaite; Katharine H D Crawford; Caelan E Radford; Ariana G Farrell; Timothy C Yu; William W Hannon; Panpan Zhou; Raiees Andrabi; Dennis R Burton; Lihong Liu; David D Ho; Richard A Neher; Jesse D Bloom
Journal:  bioRxiv       Date:  2022-10-13

7.  Cysteamine exerts in vitro antiviral activity against the SARS-CoV-2 Delta and Omicron variants.

Authors:  Tonino Alonzi; Alessandra Aiello; Federica Repele; Laura Falasca; Massimo Francalancia; Anna Rosa Garbuglia; Giovanni Delogu; Emanuele Nicastri; Mauro Piacentini; Delia Goletti
Journal:  Cell Death Discov       Date:  2022-06-15

8.  Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections.

Authors:  Iris Medits; David N Springer; Marianne Graninger; Jeremy V Camp; Eva Höltl; Stephan W Aberle; Marianna T Traugott; Wolfgang Hoepler; Josef Deutsch; Oliver Lammel; Christian Borsodi; Elisabeth Puchhammer-Stöckl; Alexander Zoufaly; Lukas Weseslindtner; Judith H Aberle; Karin Stiasny
Journal:  Front Immunol       Date:  2022-07-19       Impact factor: 8.786

9.  Neutralizing monoclonal antibodies against SARS-CoV-2 for COVID-19 pneumonia in a rituximab treated patient with systemic sclerosis-A case report and literature review.

Authors:  Melek Yalcin Mutlu; Jule Taubmann; Jochen Wacker; Koray Tascilar; Filippo Fagni; Maximilian Gerner; Daniel Klett; Georg Schett; Bernhard Manger; David Simon
Journal:  Front Med (Lausanne)       Date:  2022-08-03

10.  Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines.

Authors:  Li Wang; Markus H Kainulainen; Nannan Jiang; Han Di; Gaston Bonenfant; Lisa Mills; Michael Currier; Punya Shrivastava-Ranjan; Brenda M Calderon; Mili Sheth; Brian R Mann; Jaber Hossain; Xudong Lin; Sandra Lester; Elizabeth A Pusch; Joyce Jones; Dan Cui; Payel Chatterjee; M Harley Jenks; Esther K Morantz; Gloria P Larson; Masato Hatta; Jennifer L Harcourt; Azaibi Tamin; Yan Li; Ying Tao; Kun Zhao; Kristine Lacek; Ashley Burroughs; Wei Wang; Malania Wilson; Terianne Wong; So Hee Park; Suxiang Tong; John R Barnes; Mark W Tenforde; Wesley H Self; Nathan I Shapiro; Matthew C Exline; D Clark Files; Kevin W Gibbs; David N Hager; Manish Patel; Alison L Halpin; Laura K McMullan; Justin S Lee; Hongjie Xia; Xuping Xie; Pei-Yong Shi; C Todd Davis; Christina F Spiropoulou; Natalie J Thornburg; M Steven Oberste; Vivien G Dugan; David E Wentworth; Bin Zhou
Journal:  Nat Commun       Date:  2022-07-27       Impact factor: 17.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.